Dive into our dynamic, ever-growing library of peer-reviewed publications, posters, application notes, and presentations showcasing the full breadth and depth of Trajan microsampling technologies. Discover cutting-edge methods, compelling scientific breakthroughs, and real-world applications spanning a wide range of disciplines.
This protocol describes the ON-TARGET study, which evaluates routine therapeutic drug monitoring for targeted oral anticancer drugs. It also tests VAMS collection as a step toward a nationwide, home-compatible monitoring infrastructure.
This study examined behavioral and physiological features of apathy in aged male mice. Changes in motivation, reward sensitivity, and emotional reactivity supported the model’s potential for preclinical apathy research.
This prospective protocol evaluates minimally invasive blood, skin, and urine tests for diagnosing and confirming cure of visceral leishmaniasis in people with HIV. The study is designed to assess alternatives to invasive splenic or bone-marrow sampling.
This protocol evaluates telemedicine versus usual epilepsy care and includes VAMS finger-prick sampling for anti-seizure medication measurement. The study will compare VAMS with plasma and assess nurse-collected versus self-collected samples.
This study evaluated several low-volume blood-sampling technologies in nonclinical and clinical settings. The findings demonstrate feasibility while identifying practical considerations that should guide implementation and comparison with venipuncture.
This article reviews the operational impact of the COVID-19 pandemic on bioanalysis and drug development. It highlights how rapid process changes, collaboration, and removal of longstanding barriers enabled continued study support and accelerated pandemic-related work.
This review summarizes the use of VAMS in COVID-19 research, antibody testing, and remote sample collection. The published evidence supports VAMS as an effective alternative when conventional phlebotomy is impractical.
This proof-of-concept study adapted an automated anti-SARS-CoV-2 immunoassay for volumetric dried-blood samples. Results supported dried microsamples as a practical alternative to serum or plasma for antibody testing.
This study evaluated whole-blood stability of daclizumab and trastuzumab on VAMS devices. The findings help define handling and analysis timelines for large-scale antibody studies and remote sample collection.
This study evaluated remote finger-stick blood collection for SARS-CoV-2 antibody testing with a commercial immunoassay. Dried-blood extracts showed near-identical sensitivity and specificity to serum, supporting at-home and large-scale seroprevalence testing.
Microsampling and Microbiopsy specialists are available to provide expert support for the success of your project.
